Autopsy report · NCT05316467

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

“no enough enrolled patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 10 months before it stopped.
• 8 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Xiaojun Chen

Sponsor type

University, hospital or other

Conditions

Endometrial Carcinoma; Obese; Overweight; Fertility Issues

Interventions

Intensive Lifestyle Intervention (ILI); Megestrol Acetate 160 MG Oral Tablet

Participants

8

Sites

1

Countries

China

Trials that died the same way

• Study of Image-Guided SBRT for Vertebral Metastases
  “not sufficient patients enrolled” (85% match in meaning)
• Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
  “Not enough eligible patients available” (84% match in meaning)
• Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
  “Could not enroll enough patients.” (84% match in meaning)
• Ethanol Locks for the Treatment of Central Venous Line Infections
  “inability to enroll adequate number of patients” (82% match in meaning)
• Epidermal Cells Delivery and Acute Burns
  “Not enough patients included” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.